Smart nanocomposite assemblies for multimodal cancer theranostics

Int J Pharm. 2022 Apr 25:618:121697. doi: 10.1016/j.ijpharm.2022.121697. Epub 2022 Mar 22.

Abstract

Despite great strides in anticancer research, performance statistics of current treatment modalities remain dismal, highlighting the need for safe, efficacious strategies for tumour mitigation. Non-invasive fusion technology platforms combining photodynamic, photothermal and hyperthermia therapies have emerged as alternate strategies with potential to meet many of the unmet clinical demands in the domain of cancer. These therapies make use of metallic and magnetic nanoparticles with light absorbing properties, which are manipulated to generate either reactive cytotoxic oxygen species or heat for tumour ablation. Combination therapies integrating light, heat and magnetism-mediated nanoplatforms with the conventional approaches of chemotherapy, radiotherapy and surgery are emerging as precision medicine for targeted interventions against cancer. This article aims to compile recent developments of advanced nanocomposite assemblies that integrate multimodal therapeutics for cancer treatment. Amalgamation of various effective, non-invasive technological platforms such as photodynamic therapy (PDT), photothermal therapy (PTT), magnetic hyperthermia (MHT), and chemodynamic therapy (CDT) have tremendous potential in presenting safe and efficacious solutions to the formidable challenges in cancer therapeutics.

Keywords: Cancer; Chemodynamic therapy; Magnetic hyperthermia; Magnetic nanoparticles; Photodynamic therapy; Photothermal therapy.

Publication types

  • Review

MeSH terms

  • Humans
  • Hyperthermia, Induced*
  • Nanocomposites*
  • Neoplasms* / therapy
  • Photochemotherapy*
  • Precision Medicine
  • Reactive Oxygen Species

Substances

  • Reactive Oxygen Species